GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
Someday such a drug that is the real deal might be proven, but again were not there yet
take 2 capsules daily or as directed by your healthcare practitioner* As the #1 Doctor Recommended Professional Supplement Brand, Metagenics delivers clinically proven, precision-crafted formulas to support your health at its corebecause true wellness starts with integrity, balance, and expertise
Scurvy occurs when intake is below 10 mg per day
Regular follow-up is essential to assess therapeutic response, monitor glycemic and cardiovascular outcomes, and manage adverse effects
